Guardant sells blood tests that detect and monitor cancer.
Guardant Health, Inc. (GH) is expected to report earnings on Thursday, November 5, 2026, after the close. Estimated release time 16:09 ET. Consensus EPS estimate is $-0.75.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | Jun 2026 qtr | $-0.76 | $-0.90 | — | $334.98M |
| 2026-05-07 | Mar 2026 qtr | $-0.81 | $-0.85 | — | $301.67M |
| 2026-02-19 | Dec 2025 qtr | $-0.77 | $-0.90 | — | $281.27M |
| 2025-10-29 | Sep 2025 qtr | $-0.48 | $-0.39 | — | $265.20M |
| 2025-07-30 | Jun 2025 qtr | $-0.52 | $-0.44 | — | $232.09M |
| 2025-04-30 | Mar 2025 qtr | $-0.61 | $-0.49 | — | $203.47M |
| 2025-02-20 | Dec 2024 qtr | $-0.75 | $-0.62 | — | $201.81M |
| 2024-11-06 | Sep 2024 qtr | $-0.55 | $-0.45 | — | $191.48M |